Astex Technology, the Fragment-Based Drug Discovery and Development Company, Today Announced Issuance of Patent GB2395718 Covering the Use of the Crystal Structure of Human Cytochrome P450 3A4, the Most Important Drug Metabolising Enzyme in Man

CAMBRIDGE, United Kingdom, Jan. 24, 2005 (PRIMEZONE) -- Astex Technology:

Full press release attached below:


Contact Data